BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17919549)

  • 1. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
    Kitade M; Kumakiri J; Kobori H; Murakami K
    Trials; 2024 May; 25(1):343. PubMed ID: 38790029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
    Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE
    Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
    Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HOD; Li Y; McKain L; Arjona Ferreira JC; Langenberg AGM; Wagman RB; Stewart EA
    N Engl J Med; 2021 Feb; 384(7):630-642. PubMed ID: 33596357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
    Obstet Gynecol; 2022 Dec; 140(6):920-930. PubMed ID: 36357960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial.
    Brown E; Kroll R; Li H; Ng J; Pinsky B; Rodriguez JW; Thomas J; Snabes MC
    Obstet Gynecol; 2023 Nov; 142(5):1068-1076. PubMed ID: 37769311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline.
    Venturella R; Lukes AS; Wu R; McLean R; Rakov VG; Al-Hendy A
    Int J Gynaecol Obstet; 2024 May; 165(2):431-441. PubMed ID: 38576220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
    Short V; Allen R; Earley CJ; Bahrain H; Rineer S; Kashi K; Gerb J; Auerbach M
    Am J Hematol; 2024 Jun; 99(6):1077-1083. PubMed ID: 38476079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study.
    Nieman LK; Blocker W; Nansel T; Mahoney S; Reynolds J; Blithe D; Wesley R; Armstrong A
    Fertil Steril; 2011 Feb; 95(2):767-72.e1-2. PubMed ID: 21055739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women.
    Saha L; Pandhi P; Gopalan S; Malhotra S; Saha PK
    MedGenMed; 2007 Jan; 9(1):1. PubMed ID: 17435611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial.
    Kawahara N; Kawaguchi R; Yamamoto K; Nishikawa K; Matsuoka M; Maehana T; Fukui Y; Yamanaka S; Sugimoto S; Iwai K; Yamada Y; Kurakami H; Hirata T; Takashima R; Suzuki S; Asada K; Kasahara M; Kimura F
    Trials; 2024 Jan; 25(1):68. PubMed ID: 38243317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial.
    Al-Hendy A; Zhou YF; Faustmann T; Groettrup-Wolfers E; Laapas K; Parke S; Seitz C
    F S Sci; 2023 Nov; 4(4):317-326. PubMed ID: 37437885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Komatsu N; Arita K; Mitsui H; Nemoto T; Hanaki K
    Int J Hematol; 2021 Jul; 114(1):8-17. PubMed ID: 33719027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia management in non-menopausal women in a primary care setting: a prospective evaluation of clinical practice.
    Bayen S; Le Grand C; Bayen M; Richard F; Messaadi N
    BMC Fam Pract; 2020 Jan; 21(1):13. PubMed ID: 31964335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.
    Howell A; Ashcroft L; Fallowfield L; Eccles DM; Eeles RA; Ward A; Brentnall AR; Dowsett M; Cuzick JM; Greenhalgh R; Boggis C; Motion J; Sergeant JC; Adams J; Evans DG
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):58-66. PubMed ID: 29097444
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical analysis of acute postoperative pain after total laparoscopic hysterectomy for adenomyosis and uterine fibroids - a prospective observational study.
    Wu Q; Zhou Y; Sun S; Li H; Cao S; Shou H
    Ann Med; 2023; 55(2):2281510. PubMed ID: 37994446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron replacement therapy in the routine management of blood donors.
    Bryant BJ; Yau YY; Arceo SM; Daniel-Johnson J; Hopkins JA; Leitman SF
    Transfusion; 2012 Jul; 52(7):1566-75. PubMed ID: 22211316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial.
    Froessler B; Palm P; Weber I; Hodyl NA; Singh R; Murphy EM
    Ann Surg; 2016 Jul; 264(1):41-6. PubMed ID: 26817624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iron in pre-operative stage and transfusion in patients undergoing hysterectomy].
    Campos-Aguirre E; Bravo-Acevedo A; Benitez-Arvizu G
    Rev Med Inst Mex Seguro Soc; 2023 Oct; 61(Suppl 3):S453-S459. PubMed ID: 37934912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.